Radiotherapy Plus Cetuximab for Squamous Cell Carcinoma of the Oral Cavity: A Multicenter Retrospective Study of 79 Patients in Japan

There are a few reports that focus on radiotherapy (RT) and cetuximab (CET) therapy exclusively for oral cancer. This retrospective study aimed to investigate the efficacy and safety of RT and CET therapy for locally advanced (LA) or recurrent/metastatic (R/M) oral squamous cell carcinoma (OSCC). Se...

Descripción completa

Detalles Bibliográficos
Autores principales: Otsuru, Mitsunobu, Yanamoto, Souichi, Yamada, Shin-ichi, Nakashiro, Kohichi, Harazono, Yosuke, Kohgo, Tomoyuki, Nakamura, Moriyoshi, Nomura, Takeshi, Kasamatsu, Atsushi, Tanaka, Susumu, Kirita, Tadaaki, Kioi, Mitomu, Ogawa, Masaru, Sasaki, Masashi, Ota, Yoshihide, Umeda, Masahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002461/
https://www.ncbi.nlm.nih.gov/pubmed/36901553
http://dx.doi.org/10.3390/ijerph20054545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002461/
https://www.ncbi.nlm.nih.gov/pubmed/36901553
http://dx.doi.org/10.3390/ijerph20054545

Ejemplares similares